Evidence map›Paper›PMID 41459586›Full record

ArticleComputational and structural biotechnology journal2025

Explainable machine learning for prognostic modeling of waitlist mortality in cirrhotic liver transplantation.

Abdelghani Halimi, Nesma Houmani, Sonia Garcia-Salicetti, Ilias Kounis, Audrey Coilly, Eric Vibert

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abdelghani HalimiSAMOVAR, Télécom SudParis, Institut Polytechnique de Paris, 91120, Palaiseau, France.
Nesma HoumaniSAMOVAR, Télécom SudParis, Institut Polytechnique de Paris, 91120, Palaiseau, France.
Sonia Garcia-SalicettiSAMOVAR, Télécom SudParis, Institut Polytechnique de Paris, 91120, Palaiseau, France.
Ilias KounisAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Inserm UMR-S 1193, Université Paris- Saclay, Villejuif, France.
Audrey CoillyAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Inserm UMR-S 1193, Université Paris- Saclay, Villejuif, France.
Eric VibertChaire BOPA, Rue de la Chapelle de l'Hôpital, Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate mortality prediction in liver transplant (LT) candidates is essential for improving organ allocation and prioritization. Models like Model for End-Stage Liver Disease (MELD) are widely used, but may overlook complex nonlinear interactions between risk factors. Machine learning (ML) offers improved predictive accuracy but often at the expense of interpretability. In this study, we conduct a comprehensive comparison of three MELD-based scores against advanced ML models, including LDA, TabNet, RF and LightGBM to predict 3-, 6-, and 12-month waitlist mortality, using retrospective data from the UNOS/OPTN registry. SHapley Additive exPlanations (SHAP) were exploited to provide deeper insights into the best model's decision-making process, offering both global and local explanations while pinpointing key risk factors. LightGBM emerged as the best-performing model achieving AUROC of 0.921, 0.892, and 0.872 for 3-, 6-, and 12-month mortality predictions, respectively. Moreover, our proposed Ensemble Learning Transplant Mortality (ELTM) score, derived from LightGBM, not only enhanced overall risk assessment but also improved equity and patient prioritization. The explanation component highlighted key predictors beyond traditional MELD components, such as patient's functional state, age at registration, degree of ascites, and bilirubin changes over time. By introducing an explainable ML framework for prognostic modeling, this study provides a transparent data-driven approach that could enhance the efficiency and fairness of organ allocation, potentially saving lives by prioritizing patients more accurately.

Indexed as

Liver transplantationMachine learningModel explainabilityMortality risk factorsOrgan allocationPersonalized medicineRisk scoring system

Identifiers

PMID41459586
PMCPMC12743420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.